Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 2Hypertension 1

Interventions

Metformin 6Spironolactone 4ganirelix 3Progesterone 3Pioglitazone 2Ovidrel 2Methyltestosterone 2Hydrocortisone 2Estradiol 2Cosyntropin 2Thyrotropin 1Testosterone 1Ortho Evra 1Luteinizing Hormone 1Leuprolide 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Inositol 1Flutamide 1Dexamethasone 1Contraception 1Body Mass Index 1Blood Urea Nitrogen 1Adrenocorticotropic Hormone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Polycystic Ovary Syndrome × Methyltestosterone × Clear all
NCT04327934 2024-02-02

Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome

Yale University

Phase EARLY_PHASE1 Terminated
28 enrolled 17 charts

Hypertension, Polycystic Ovary Syndrome

NCT00757185 2016-07-04

Compromised Microcirculation in Women With Polycystic Ovary Syndrome

Yale University

Phase EARLY_PHASE1 Completed
28 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡